Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Important Safety Information for Gynazole•1® Butoconazole Nitrate Vaginal Cream USP, 2%
Butoconazole Nitrate Vaginal Cream USP, 2%. For the treatment of vulvovaginal candidiasis (VVC) in non-pregnant women.
Gynazole•1 Butoconazole Nitrate Vaginal Cream USP, 2% is contraindicated in patients with a history of hypersensitivity to any components of the product.
This cream contains mineral oil. Mineral oil may weaken latex or rubber products such as condoms or vaginal contraceptive diaphragms; therefore, use of such products within 72 hours following treatment with Gynazole•1 is not recommended.
Recurrent vaginal yeast infections, especially those that are difficult to eradicate, can be an early sign of infection with the human immunodeficiency virus (HIV) in women who are considered at risk for HIV infection.
If clinical symptoms persist, tests should be repeated to rule out other pathogens, to confirm original diagnosis, and to rule out other conditions that may predispose a patient to recurrent vaginal fungal infections.
5.7% of patients (18/314) receiving Gynazole•1 reported complaints such as vulvar/vaginal burning, itching, soreness and swelling, pelvic or abdominal pain or cramping, or a combination of two or more of these symptoms.
- 2% of patients discontinued treatment due to adverse events
- 1% of patients were evaluated to have treatment-related complaints
Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.